Le système des retraites en France
Le système des retraites en France, repose sur un système simple et néanmoins original : celui de la répartition.
Latest
FDA Advisory Committee recommends approval of Eli Lilly donanemab
SPECIAL REPORT 24.06
US FDA Advisory Committee recommends approval of Eli Lilly donanemab
On June 10, 2024, the US FDA Peripheral and Central Nervous System Drugs Advisory Committee panel recommended approval of Eli Lilly’s donanemab for the treatment of early-stage Alzheimer’s disease.
The panel voted 11-0 that
Les Thérapeutiques de la Maladie D’Alzheimer
Congrès SDS: Le Cerveau dans tous ses Etats ( Marseille, le 31 mai 2024) Les Thérapeutiques de la Maladie D’Alzheimer: Faits, Tendances et Obstacles.
Oil and semiconductors: a story that repeats itself but is not the same.
By Jean-Claude Muller and John-Guy Park
Summary
"Oil and semiconductors: a story that repeats itself but is not the same"explores the parallels between oil and semiconductors, two crucial resources that have shaped not only technology and industry, but also global geopolitics. Oil, long considered the lifeblood of
Stroke : An update
SPECIAL REPORT 24.05 Stroke: An Update This report is an update from the paper published on February 28, 2022.
Hearing loss and aging
Hearing Loss and Aging This article has been published in the February issue of MedNous in a different format.
2024 Perspectives for Biotechnology Companies
SPECIAL REPORT 24.02
2024 Perspectives for Biotechnology Companies
For many, if not for most biotechnology companies, 2023 has been a dreadful and frustrating year.
Annus horribilis
said the CEO of one of them, who had to restructure his organisation with drastic job cuts and who barely survived. Reasons were